Home Physical Sciences The crystal structure of (Z)-3-((2-(2-(2-aminophenoxy)ethoxy)phenyl)amino)-1-phenylbut-2-en-1-one, C24H24N2O3
Article Open Access

The crystal structure of (Z)-3-((2-(2-(2-aminophenoxy)ethoxy)phenyl)amino)-1-phenylbut-2-en-1-one, C24H24N2O3

  • Weilian Zhang ORCID logo , Zhenyu Zuo EMAIL logo , Chen Yanhui and Liu Bin
Published/Copyright: February 23, 2021

Abstract

C24H24N2O3, monoclinic, P21/n (no. 14), a = 13.674(3) Å, b = 7.3900(14) Å, c = 20.862(4) Å, β = 106.728(7)°, V = 2018.9(7) Å3, Z = 4, Rgt(F) = 0.0633, wRref(F2) = 0.1804, T = 293 K.

CCDC no.: 2047026

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colourless block
Size:0.23 × 0.21 × 0.20 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.09 mm−1
Diffractometer, scan mode:Bruker Apex-II, φ and ω
θmax, completeness:25.0°, 99%
N(hkl)measured, N(hkl)unique, Rint:13143, 3530, 0.062
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 1844
N(param)refined:264
Programs:Bruker [1], SHELX [2], Olex2 [3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
C10.6986 (2)0.4610 (4)0.33550 (15)0.0508 (8)
C20.7324 (3)0.4662 (4)0.40478 (16)0.0614 (9)
H20.68500.47170.42890.074*
C30.8348 (3)0.4635 (5)0.43842 (17)0.0703 (10)
H30.85580.46850.48490.084*
C40.9066 (3)0.4535 (5)0.40386 (18)0.0737 (10)
H40.97580.45150.42690.088*
C50.8746 (2)0.4462 (5)0.33398 (17)0.0655 (10)
H50.92220.43780.31000.079*
C60.7722 (2)0.4516 (4)0.30107 (15)0.0516 (8)
C70.7976 (2)0.4539 (5)0.19064 (14)0.0549 (8)
H7A0.83900.34510.19670.066*
H7B0.84230.55860.20020.066*
C80.7259 (2)0.4633 (4)0.12108 (14)0.0537 (8)
H8A0.67490.36850.11450.064*
H8B0.69130.57940.11380.064*
C90.7329 (2)0.4139 (4)0.00945 (15)0.0508 (8)
C100.6318 (2)0.4615 (5)−0.01889 (16)0.0598 (9)
H100.59540.51700.00700.072*
C110.5851 (2)0.4265 (5)−0.08572 (17)0.0652 (10)
H110.51710.4585−0.10460.078*
C120.6382 (2)0.3447 (4)−0.12453 (16)0.0632 (9)
H120.60590.3206−0.16940.076*
C130.7390 (2)0.2982 (4)−0.09730 (15)0.0557 (8)
H130.77430.2425−0.12390.067*
C140.7884 (2)0.3334 (4)−0.03082 (15)0.0459 (7)
C150.9706 (2)0.3223 (4)−0.08844 (14)0.0567 (9)
H15A1.03720.3589−0.09010.085*
H15B0.92310.4193−0.10410.085*
H15C0.94910.2180−0.11640.085*
C160.9745 (2)0.2762 (4)−0.01741 (14)0.0445 (7)
C171.0673 (2)0.2308 (4)0.02690 (14)0.0483 (8)
H171.12410.22950.01090.058*
C181.0824 (2)0.1860 (4)0.09499 (15)0.0470 (8)
C191.1877 (2)0.1466 (4)0.14006 (15)0.0465 (8)
C201.2758 (2)0.1954 (4)0.12423 (16)0.0588 (9)
H201.27100.25080.08340.071*
C211.3707 (3)0.1622 (5)0.16862 (18)0.0717 (10)
H211.42940.19600.15770.086*
C221.3785 (3)0.0790 (5)0.22905 (18)0.0719 (10)
H221.44230.05710.25900.086*
C231.2914 (3)0.0287 (4)0.24488 (16)0.0622 (9)
H231.2965−0.02860.28540.075*
C241.1973 (3)0.0624 (4)0.20133 (15)0.0550 (8)
H241.13900.02870.21280.066*
N10.5959 (2)0.4638 (4)0.29936 (14)0.0720 (9)
H1A0.57560.35410.29020.086*
H1B0.56130.51320.32320.086*
N20.89046 (18)0.2845 (3)0.00320 (12)0.0500 (7)
H2A0.90010.25500.04440.060*
O10.73090 (15)0.4513 (3)0.23229 (10)0.0643 (7)
O20.78584 (14)0.4406 (3)0.07565 (9)0.0585 (6)
O31.00963 (16)0.1834 (3)0.12094 (10)0.0664 (7)

Source of material

To the solution of 2,2′-(ethane-1,2-diylbis(oxy))dianiline (0.244 g 1 mmol) in ethanol (20 ml) was added the solution of benzoylacetone 0.162 g (1 mmol) in ethanol (20 ml) dropwisely. The mixture was refluxed for 8 h then cooled and filtered to get a white solid. The solid was washed with ethanol for three times, dried and purified by column chromatography (the developing agent was dichloromethane: Petroleum ether = 1:1) to get (Z)-3-((2-(2-(2-aminophenoxy)ethoxy)phenyl)amino)-1-phenylbut-2-en-1-one (0.194 g, the yield 50%). The single crystal suitable for X-ray diffraction was obtained by recrystallization in diethyl ether.

Experimental details

The data were scaled and corrected for absorption using SADABS-2016/2 (Bruker, APEX–II CCD). The hydrogen atoms were placed at calculated positions and refined as riding atoms with isotropic displacement parameters.

Comment

α,β-Unsaturated ketones [4], [5] are highly appreciated because they have shown promising biological activities such as anti-inflammatory [6], [7], antimicrobial [8], anti-parasitic [9], antibacterial [10], antimalarial [11], antitumor [12], anti-nematodal [13], antioxidant [14] and anti-tubulin [15] activities. The synthesis and activity research of the novel α,β-unsaturated ketones have drawn more and more attentions in recent decades.

This contribution is part of a study on amine-based organic molecules [16]. The title compound (Z)-3-((2-(2-(2-aminophenoxy)ethoxy)phenyl)amino)-1-phenylbut-2-en-1-one was synthesized by condensation reaction using 2,2′-(ethane-1,2-diylbis(oxy))dianiline as the starting material. There is one molecule in the asymmetric unit (see the figure). The angles of O3–C18–C19, C16–N2–C14 and C6–O1–C7 are 117.4(3), 131.5(2) and 119.3(2)° respectively, which are in normal range. Hydrogen bonds were observed as following: N1–H1B⋅⋅⋅O3 hydrogen bond (d(H1B⋅⋅⋅O3) = 2.13 Å, N2–H2A⋅⋅⋅O2 hydrogen bond (d(H2A⋅⋅⋅O2) = 2.31 Å, N2–H2A⋅⋅⋅O3 hydrogen bond (d(H2A⋅⋅⋅O3) = 1.92 Å.


Corresponding author: Zhenyu Zuo, College of Pharmacy, Shaanxi University of Chinese Medicine, Xi’an, Shaanxi, 712046, China; and Shaanxi Key Laboratory of Basic and New Herbal Medicament Research, Xi’an, 712046, China, E-mail:

Funding source: National Key R&D program of China

Award Identifier / Grant number: 2018YFC1706903

Funding source: Key projects of Shaanxi Provincial Education Department

Award Identifier / Grant number: 20JS033

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: The research was supported by the National Key R&D program of China (2018YFC1706903), Key projects of Shaanxi Provincial Education Department (20JS033).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Bruker. APEX2, SAINT and SADABS; Bruker AXS Inc.: Madison, Wisconsin, USA, 2012.Search in Google Scholar

2. Sheldrick, G. M. Crystal structure refinement with ShelXL. Acta Crystallogr. 2015, C27, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar

3. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. Olex2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Search in Google Scholar

4. Zhang, L., Qi, L., Fang, Y. (Z)-3-(2–Methoxyanilino)-1-phenylbut-2-en-1-one. Acta Crystallogr. 2010, E66, o576; https://doi.org/10.1107/s1600536810004460.Search in Google Scholar

5. Shi, Y., Hu, Y. Syntheses and structures of copper complexes of tetradentate enaminones derived from condensation of benzoylacetone and ferrocenoylacetone with 1,2-bis(2-aminophenoxy)ethane. J. Coord. Chem. 2009, 62, 1302–1312; https://doi.org/10.1080/00958970802573028.Search in Google Scholar

6. Araico, A., Terencio, M. C., Alcaraz, M. J., Dominguez, J. N., Leon, C., Ferrandiz, M. L. Evaluation of the anti-inflammatory and analgesic activity of Me–UCH9, a dual cyclooxygenase-2/5-lipoxygenase inhibitor. Life Sci. 2007, 80, 2108–2117; https://doi.org/10.1016/j.lfs.2007.03.017.Search in Google Scholar PubMed

7. Leong, S., Faudzi, S., Abas, F., Aluwi, M., Rullah, K., Wai, L., Bahari, M., Ahmad, S., Tham, C., Shaari, K. Synthesis and sar study of diaryl pentanoid analogues as new anti-inflammatory agents. Molecules 2014, 19, 16058–16081; https://doi.org/10.3390/molecules191016058.Search in Google Scholar PubMed PubMed Central

8. Din, Z. U., Serrano, N. F. G., Ademi, K., Sousa, C. P., Deflon, V. M., da Silva Maia, P. I., Rodrigues-Filho, E. Crystal structures, in-silico study and anti-microbial potential of synthetic monocarbonyl curcuminoids. J. Mol. Struct. 2017, 1144, 529–534.10.1016/j.molstruc.2017.05.061Search in Google Scholar

9. Braga, S. F., Alves, E. V., Ferreira, R. S., Fradico, J. R., Lage, P. S., Duarte, M. C., Ribeiro, T. G., Júnior, P. A., Romanha, A. J., Tonini, M. L. Synthesis and evaluation of the antiparasitic activity of bis-(arylmethylidene) cycloalkanones. Eur J. Med. Chem. 2014, 71, 282–289; https://doi.org/10.1016/j.ejmech.2013.11.011.Search in Google Scholar PubMed

10. Batovska, D., Parushev, S., Stamboliyska, B., Tsvetkova, I., Ninova, M., Najdenski, H. Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted. Eur. J. Med. Chem. 2009, 44, 2211–2218; https://doi.org/10.1016/j.ejmech.2008.05.010.Search in Google Scholar PubMed

11. Franco, L. L., de Almeida, M. V., e Silva, L. F. R., Vieira, P. P. R., Pohlit, A. M., Valle, M. S. Synthesis and antimalarial activity of dihydroperoxides and tetraoxanes conjugated with bis (benzyl) acetone derivatives. Chem. Biol. Drug Des. 2012, 79, 790–797; https://doi.org/10.1111/j.1747-0285.2012.01345.x.Search in Google Scholar PubMed

12. Cabrera, M., Simoens, M., Falchi, G., Lavaggi, M. L., Piro, O. E., Castellano, E. E., Vidal, A., Azqueta, A., Monge, A., de Cerain, A. L. Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships. Bioorg. Med. Chem. 2007, 15, 3356–3367; https://doi.org/10.1016/j.bmc.2007.03.031.Search in Google Scholar PubMed

13. Attar, S., OBrien, Z., Alhaddad, H., Golden, M. L., Calderon-Urrea, A. Ferrocenyl chalcones versus organic chalcones: a comparative study of their nematocidal activity. Bioorg. Med. Chem. 2011, 19, 2055–2073; https://doi.org/10.1016/j.bmc.2011.01.048.Search in Google Scholar PubMed

14. Gacche, R., Khsirsagar, M., Kamble, S., Bandgar, B., Dhole, N., Shisode, K., Chaudhari, A. Antioxidant and anti-inflammatory related activities of selected synthetic chalcones: structure-activity relationship studies using computational tools. Chem. Pharm. Bull. 2008, 56, 897–901; https://doi.org/10.1248/cpb.56.897.Search in Google Scholar PubMed

15. Zhang, H., Liu, J.-J., Sun, J., Yang, X.-H., Zhao, T.-T., Lu, X., Gong, H.-B., Zhu, H.-L. Design, synthesis and biological evaluation of novel chalcone derivatives as antitubulin agents. Bioorg. Med. Chem. 2012, 20, 3212–3218; https://doi.org/10.1016/j.bmc.2012.03.055.Search in Google Scholar PubMed

16. Zuo, Z., Lei, F., Song, X., Wang, L. The crystal structure of N,N-diethyl-4,6-bis(naphthalen-2-yloxy)-1,3,5-triazin-2-amine, C27H24N4O2. Z. Kristallogr. NCS 2018, 233, 1083–1085; https://doi.org/10.1515/ncrs-2018-0207.Search in Google Scholar

Received: 2021-01-14
Accepted: 2021-02-01
Published Online: 2021-02-23
Published in Print: 2021-05-26

© 2021 Weilian Zhang et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. The crystal structure of bis(μ2-5-chloro-2-oxido-N-(1-oxidoethylidene)benzohydrazonato-κ5N,O,O′:N′,O′′)hexkis(pyridine-κ1N)trinickel(II) - pyridine (1/1), C63H57Cl2N13Ni3O6
  4. Crystal structure of [(μ2-succinato κ3O,O′:O′′)-bis-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane)]dinickel(II)] diperchlorate, dihydrate C36H82Cl2N8Ni2O15
  5. Crystal structure of catena-poly[aquabis(3-nitrobenzoato-κ2O:O′)-(μ2-pyrazine-N: N′)cadmium(II)], C18H14N4O9Cd
  6. Crystal structure of 4-(2,2-difluoroethyl)-2,4,6-trimethylisoquinoline-1,3(2H,4H)-dione, C14H15F2NO2
  7. The crystal structure of thioxanthen-9-one-10,10-dioxide, C13H8O3S – a second polymorph
  8. Crystal structure of (E)-2-((2-methoxy-3-pyridyl)methylene)-7-fluoro-3,4-dihydronaphthalen-1(2H)-one, C17H14FNO2
  9. The crystal structure of diaquahydrogen 2,5-dimethylbenzenesulphonate, C8H14O5S
  10. The crystal structure of N-(4-(cyclohexylimino)pent-2-en-2-yl)cyclohexanamine, C17H30N2
  11. The twinned crystal structure of 1,3-phenylenedimethanaminium dibromide, C8H14Br2N2
  12. Crystal structure of 2,4,7,9-tetranitro-10H-benzofuro[3,2-b]indole – dimethyl sulfoxide (1/1), C16H11N5O10S
  13. Crystal structure of 2,6-bis(2-(pyridin-3-yl)ethyl)pyrrolo[3,4-f]isoindole-1,3,5,7(2H,6H)-tetraone, C24H18N4O4
  14. The crystal structure of 3,4-dichlorobenzoic acid chloride, C7H3Cl3O
  15. Crystal structure of 1,1′-(1,4-phenylenebis(methylene))bis(pyridin-1-ium) bis(1,2-dicyanoethene-1,2-dithiolato-k2S:S)zinc(II), C26H18N6ZnS4
  16. Crystal structure of tetrakis(μ-naphthalene-1-carboxylato-κ2O,O′)bis(methanol)copper(II), C46H36Cu2O10
  17. Crystal structure of 9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one, C14H13NO
  18. Crystal structure of bis(amino(carbamothioylamino)methaniminium) 3-nitrophthalate monohydrate, C12H19N9O7S2
  19. Crystal structure of 3,3′-(1,2-phenylene-bis(methylene))bis(1-ethyl-1H-imidazol-3-ium) bis(hexafluorophosphate), C18H24F12N4P2
  20. The crystal structure of 5-hydroxy-6,8-dimethoxy-2-methyl-4H-benzo[g]chromen-4-one– rubrofusarin B, C16H14O5
  21. The crystal structure of bis(ethanol-kO)- bis(6-aminopicolinato-k2N,O)manganese(II), C16H22O6N4Mn
  22. The crystal structure of 3,3′-((carbonylbis(azanediyl))bis(ethane-2,1-diyl)) bis(1-methyl-1H-benzo[d]imidazol-3-ium) tetrafluoroborate monohydrate, C21H28N6O3B2F8
  23. Crystal structure of dimethanol-dichlorido-bis( μ2-2-(((1,5-dimethyl-3-oxo-2- phenyl-2,3-dihydro-1H-pyrazol-4-yl)imino)methyl)phenolato- κ4O:O,O′,N)dinickel (II), C20H24ClNiN3O4
  24. The crystal structure of methyl 5-(trifluoromethyl)-1H-pyrrole-2-carboxylate, C7H6F3NO2
  25. Crystal structure of (OC‐6‐13)‐aqua‐tris (3‐bromopyridine‐κ1N)‐bis(trifluoroacetato‐κ1O)cadmium(II) C19H14Br3CdF6N3O5
  26. Crystal structure of methyl (E)-3-(4-(2-ethoxy-2-oxoethoxy)phenyl) acrylate, C14H16O5
  27. Crystal structure of methyl 4-acetoxy-3,5-dimethoxybenzoate, C12H14O6
  28. The crystal structure of 2-(1H-benzimidazol-2-yl)-3-bromo-5-chlorophenol, C13H8BrClN2O
  29. The crystal structure of bis(μ2-5-chloro-N-(2-methyl-1-oxidopropylidene)-2-oxidobenzohydrazonate-κ5N,O,O′:N′,O′′)pentakis(pyridine-κ1N)tricopper(II), C47H45Cl2N9Cu3O6
  30. Synthesis and crystal structure of catena-poly[aqua-bis(nitrato-κ2O:O′)- (μ2-((1 H-imidazol-1-yl)methyl)benzene-κ2 N,N′)-H2O-κ2O]cadmium(II), C14H16N6O7Cd
  31. The crystal structure of pentakis(carbonyl)-{μ-[2,3-bis(sulfanyl)propan-1-olato]}-(triphenylphosphane)diiron (FeFe)C26H21Fe2O6PS2
  32. Crystal structure of ethyl-2-(3-benzoylthioureido)propanoate, C13H16N2O3S
  33. Crystal structure of 2-methoxy-4b,5,14,15-tetrahydro-6H-isoquinolino[2′,1′:1,6] pyrazino[2,3-b]quinoxaline, C19H18N4O
  34. Crystal structure of 2,2′-[ethane-1,2-diylbis(azanylylidenemethylylidene)]bis(6-chlorophenol), C16H14Cl2N2O2
  35. The crystal structure of (Z)-3-((2-(2-(2-aminophenoxy)ethoxy)phenyl)amino)-1-phenylbut-2-en-1-one, C24H24N2O3
  36. The crystal structure of 10-(3,5-di(pyridin-4-yl)phenyl)-10H-phenoxazine dihydrate, C28H23N3O3
  37. Crystal structure of poly[dipoly[aqua-di(µ2-pyrazin-2-olato-κ2N:N′) zinc(II)], C8H8N4O3Zn
  38. Crystal structure of poly[tetra(μ2-cyanido-κ2N:O)-bis(N,N-dimethylformamide-κO)-manganese(II)-platinum(II)], C10H14MnN6O2Pt
  39. The crystal structure of aqua-chlorido-6,6′-((ethane-1,2-diylbis(azaneylylidene))bis(methaneylylidene))bis(2,4-dichlorophenolato-κ4N,N′,O,O′)manganese(III), C16H12Cl5MnN2O3
  40. Crystal structure of [di(µ2-cyanido)-dicyanido-bis(dimethyl sulfoxide-κO)- bis(2,2′-(ethane-1,2-diylbis(azanylylidenemethanylylidene))diphenolato-κ4,N,N′,O,O′)- dimanganese(III)-platinum(II)], C40H40Mn2N8O6PtS2
  41. The crystal structure of (azido)-κ1N-6,6′-((cyclohexane-1,2-diylbis(azanylylidene)) bis(methanylylidene))bis(3-bromophenolato-κ4N,N,O,O)-(methanol)-manganese(III)–methanol(1/1), C22H26Br2MnN5O4
  42. Crystal structure of 7-chloro-N-(4-iodobenzyl)-1,2,3,4-tetrahydroacridin-9-amine, C20H18ClIN2
  43. Crystal structure of catena-poly[(1,4,8,11-tetraazacyclotetradecane-κ4N,N,N,N′′′)-bis(μ2-thiocyanato-κ2N:S)-bis(thiocyanato-κS)-nickel(II)palladium(II)], C14H24N8NiPdS4
  44. Crystal structure of 3-chloro-4-(4-ethylpiperazin-1-yl)aniline monohydrate, C12H20ClN3O
  45. Crystal structure of the 2D coordination polymer poly[diaqua-bis(μ2-3- methoxyisonicotinato-κ2N:O)cobalt(II)] — dimethylformamide (1/1), C20H30CoN4O10
  46. Crystal structure of 4-[(5-chloro-2-hydroxybenzylidene)amino]-3-propyl-1H-1,2,4-triazole-5(4H)-thione, C12H13ClN4OS
  47. Crystal structure of N-(5-(2-(benzyl(1-(4-methoxyphenyl)propan-2-yl)amino)-1-hydroxyethyl)-2-(benzyloxy)phenyl)formamide, C33H36N2O4
  48. Crystal structure of 3-(methoxycarbonyl)-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid, C9H12O5
  49. The crystal structure of 1-((dimethylamino)(3-nitrophenyl)methyl)naphthalen-2-ol, C19H18N2O3
  50. Crystal structure of catena-poly[di(μ2-cyanido-κ2C:N)-dicyanido-tetrakis(dimethyl sulfoxide-κO)-manganese(II)-platinum(II)], C12H24MnN4O4PtS4
  51. Crystal structure of 4-amino-N-(2-pyrimidinyl)benzenesulfonamide–1,4-dioxane (1/1), C14H18N4O4S
  52. Crystal structure of bis{1-[(benzotriazol-1-yl)methyl]-1H-1,3-(2-methyl-imidazol)}di-chloridomercury(II), [Hg(C11H11N5)2Cl2], C22H22N10Cl2Hg
  53. Crystal structure of 2, 3-bis((4-methylbenzoyl)oxy) succinic acid–N, N-dimethylformamide (1/1), C23H25NO9
  54. Crystal structure of catena-poly[bis(4-(4-carboxyphenoxy)benzoato-κ1O)-μ2-(1,4-bis(1-imidazolyl)benzene-κ2N:N′)cobalt(II)], C40H28N4O10Co
  55. Crystal structure of 1H-imidazol-3-ium poly[aqua-(μ4-glutarato-κ6O,O′:O′:O′′,O′′′:O′′′)-(nitrato-κ2O,O′)strontium(II)], C8H13N3O8Sr
  56. Crystal structure of (R)-6-(benzo[b]thiophen-5-yl)-2-methyl-2,6-dihydrobenzo [5,6] silino[4,3,2-cd]indole, C23H17NSSi
  57. Crystal structure of catena-poly[bis(μ2-thiocyanato-κ2N:S)-(2-(5-methyl-1H-pyrazol-3-yl)pyridine-κ2N,N′)cadmium(II)]–dioxane (1/1), C15H17CdN5O2S2
  58. Crystal structure of poly[aqua-(μ2-1,4-bis(2′-carboxylatophenoxy)benzene-κ2O:O′)-(μ2-4,4′-bipyridione-κ2N:N′)cadmium(II)] monhydrate, C30H22CdN2O7⋅H2O
  59. Crystal structure of catena-poly[tetraaqua-(μ2-4,4′-bipyridine-k2N:N′)-bis(μ2-4′-methyl-[1,1′-biphenyl]-3,5-dicarboxylato-k4O,O′:O″,O′″)dicadmium(II)] dihydrate, C20H20NO7Cd
  60. Crystal structure of 1‐tert‐butyl‐3‐(2,6‐diisopropyl‐4‐phenoxyphenyl)‐2-methylisothiourea, C24H34N2OS
  61. Crystal structure of catena-poly[triaqua-(μ2-1,3-di(1H-imidazol-1-yl)propane-κ2N:N′)-(4,4′-(1H-1,2,4-triazole-3,5-diyl)dibenzoato-κ1O)cobalt(II)] — N,N′-dimethylformamide (1/1), C28H34N8O8Co
  62. Crystal structure of tetraaqua-bis(1,4-di(1H-imidazol-1-yl)benzene-κ1N)manganese(II) 2,3-dihydroxyterephthalate, C32H32MnN8O10
Downloaded on 3.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2021-0022/html
Scroll to top button